Bioavailability and Safety of Dihydroquercetin (Review)

Dihydroquercetin (DHQ) is a bioflavonoid with high antioxidant, capillary-protective, and anti-inflammatory activity. DHQ has previously been used for treating Middle East respiratory syndrome coronavirus (MERS-CoV) infection and is currently considered a potential regulator of oxidative stress as part of COVID-19 multipurpose therapy. DHQ has a high safety profile but low bioavailability that limits its use. Innovative techniques (liposomization, crystal engineering, etc.) can be used to increase its bioavailability. © 2022, Springer Science+Business Media, LLC, part of Springer Nature.

Авторы
Номер выпуска
11
Язык
Английский
Страницы
1133-1137
Статус
Опубликовано
Том
55
Год
2022
Организации
  • 1 Peoples’ Friendship University of Russia (RUDN), 6 Miklukho-Maklaya St., Moscow, 117198, Russian Federation
  • 2 A. P. Vinogradov Institute of Geochemistry, Siberian Branch, Russian Academy of Sciences, 1A Favorskogo St., P. O. Box 9, Irkutsk, 664033, Russian Federation
Ключевые слова
bioavailability; dihydroquercetin; safety; SARS-CoV-2; toxicity
Цитировать
Поделиться

Другие записи